Literature DB >> 11259258

Ovarian tumorigenesis in mice transgenic for murine inhibin alpha subunit promoter-driven Simian Virus 40 T-antigen: ontogeny, functional characteristics, and endocrine effects.

N A Rahman1, I T Huhtaniemi.   

Abstract

We previously reported formation of ovarian granulosa cell tumors with 100% penetration in a transgenic mouse model with murine inhibin alpha subunit promoter-driven (inhalpha)/Simian Virus 40 T-antigen (Tag). The tumor-bearing inhalpha/Tag mice showed highly elevated serum levels of immunoreactive inhibin. To investigate the onset of tumorigenesis and related endocrine consequences, 6-8 female mice of two inhalpha/Tag lines and their mating control littermates were killed monthly between 1 and 6 mo of age. We also investigated tumorigenesis-related fertility aspects of these two mouse lines. The ontogeny and progression of tumors could be monitored in both inhalpha/Tag lines by alterations of ovarian weights and serum hormone levels. Serum progesterone levels increased in both inhalpha/Tag lines in an age-dependent manner as ovarian tumorigenesis progressed, and a reciprocal decrease occurred in serum LH and FSH. Neither serum estradiol (E(2)) nor uterine weights were significantly altered during tumorigenesis, suggesting that the ovarian tumors represented late stages of granulosa cell differentiation. In conclusion, the present findings show in the inhalpha/Tag TG mice a relation between endocrine consequences of granulosa cell tumorigenesis, and a connection of onset of tumor formation with aberrant steroidogenesis and gonadotropin secretion. These findings indicate that tumors are endocrinologically active and able to exert enhanced negative feedback effects on pituitary function. The tumors provide a good model for endocrinologically active hormone-dependent tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259258     DOI: 10.1095/biolreprod64.4.1122

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

1.  A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.

Authors:  Gabriel Bodek; Susanna Vierre; Adolfo Rivero-Müller; Ilpo Huhtaniemi; Adam J Ziecik; Nafis A Rahman
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

Review 2.  Toying with fate: Redirecting the differentiation of adrenocortical progenitor cells into gonadal-like tissue.

Authors:  Theresa Röhrig; Marjut Pihlajoki; Ricarda Ziegler; Rebecca S Cochran; Anja Schrade; Maximiliaan Schillebeeckx; Robi D Mitra; Markku Heikinheimo; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2014-12-08       Impact factor: 4.102

3.  Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In situ -Applications in Evaluating Novel Therapeutic Agents.

Authors:  Denise C Connolly; Harvey H Hensley
Journal:  Curr Protoc Pharmacol       Date:  2009-06-01

4.  Development of a syngeneic mouse model of epithelial ovarian cancer.

Authors:  Bridget A Quinn; Fang Xiao; Laura Bickel; Lainie Martin; Xiang Hua; Andres Klein-Szanto; Denise C Connolly
Journal:  J Ovarian Res       Date:  2010-10-19       Impact factor: 4.234

5.  Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression.

Authors:  Donata Ponikwicka-Tyszko; Marcin Chrusciel; Joanna Stelmaszewska; Piotr Bernaczyk; Paulina Chrusciel; Maria Sztachelska; Mika Scheinin; Mariusz Bidzinski; Jacek Szamatowicz; Ilpo T Huhtaniemi; Slawomir Wolczynski; Nafis A Rahman
Journal:  EBioMedicine       Date:  2019-08-26       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.